ELEKTA’S TECH PROWESS NEEDS THE BACKING OF A NEW CEO (BUY; 69% UPSIDE)
13/03/25 -" Since our March 2024 idea kicker for family-controlled Elekta (Buy; Sweden) entitled ELEKTA'S CINDERELLA STORY HAS A LONG WAY TO GO, the situation has deteriorated for this leading provider of ..."
Pages
69
Language
English
Published on
13/03/25
You may also be interested by these reports :
08/05/25
Qiagen commenced 2025 positively, with robust performance in Diagnostic Solutions and PCR/Nucleic Acid Amplification, although this was partially ...
08/05/25
Demant’s Q1 results met market expectations. Growth in Hearing Care was counterbalanced by weakness in Hearing Aids. Meanwhile, Diagnostics remained ...
07/05/25
DiaSorin’s Q1 results marginally surpassed market expectations, demonstrating good performance across all segments. Profitability improved and ...
07/05/25
Q2 figures exceeded expectations, surpassing consensus estimates (sales: +2.0%; adjusted EBIT: +4.4%). This was primarily due to pre-buying ...